Bofanglutide
博凡格鲁肽
Report date: 2026/05/22 20:01:29
Base Information
Drug NameBofanglutide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesProductos Científicos S. A. De C. V.Gan And Lee Pharmaceuticals, UsaJw Pharmaceutical Corp +[6]
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A